WAUD REEVE B 4
4 · Acadia Healthcare Company, Inc. · Filed May 8, 2026
Research Summary
AI-generated summary of this filing
Acadia Healthcare (ACHC) Director Reeve B. Waud Receives Stock Award
What Happened
Reeve B. Waud, a director of Acadia Healthcare Company, Inc. (ACHC), was awarded two equity grants on May 6, 2026 totaling 15,907 shares (6,331 and 9,576 shares). The grants are recorded at $0 (awarded, not purchased) and will vest pro rata over a three‑year period beginning May 6, 2027. One of the grants reflects Mr. Waud’s election to receive his 2026 annual director cash retainer in shares.
Key Details
- Transaction date: May 6, 2026; Form 4 filed May 8, 2026 (filed within two business days).
- Grants: 6,331 shares and 9,576 shares; price reported $0.00 (award). Total new shares = 15,907.
- Vesting: Shares vest in equal annual installments over three years starting May 6, 2027 (see footnote).
- Recorded ownership (pre-existing, per filing): 653,015 shares held of record across related trusts/entities; the new awards add 15,907 to those records (total 668,922 on record).
- Beneficial ownership note: The filing explains why Mr. Waud may be deemed to beneficially own the shares held by those trusts/entities (see footnotes) but he disclaims beneficial ownership except to the extent of any pecuniary interest.
Context
This was an equity award (compensation) and an election to take a cash retainer in stock, not an open‑market purchase or sale; such awards are routine director compensation and do not by themselves indicate a personal buy/sell market signal. The filing appears timely for Section 16 reporting.
Insider Transaction Report
- Award
Common Stock
[F1]2026-05-06+6,331→ 66,283 total - Award
Common Stock
[F2]2026-05-06+9,576→ 75,859 total
- 653,015(indirect: See Footnotes)
Common Stock
[F3][F4][F5]
Footnotes (5)
- [F1]Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.
- [F2]Reflects Mr. Waud's election to receive his annual cash retainer as a director for 2026 in shares of common stock.
- [F3]The shares are owned of record as follows: (i) 225,519 shares by the Halcyon Trust, (ii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), (iii) 155,930 shares by the Reeve B. Waud Jr. 2012 Family Trust (the "2012 RBW Jr Family Trust"), (iv) 155,930 shares by the Cecily R.M. Waud 2012 Family Trust (the "2012 CRMW Family Trust"), (v) 43,643 shares by the Cornelius Byron Waud 2002 Trust (the "2002 CBW Family Trust"), and (vi) 34,500 shares by the Corinna Reeve Waud 2002 Trust ("2002 CRW Family Trust").
- [F4]Mr. Waud may be deemed to beneficially own the shares of common stock described above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being the sole manager of WCP LLC, (C) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries, and (D) his being appointed, in June 2023, as the co-trustee of the 2002 CBW Family Trust and the 2002 CRW Family Trust of which Mr. Waud's parents are beneficiaries.
- [F5]Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.